SP Nandrolone-F

Fenandrol contains nandrolone phenylpropionate as an active substance in the group of anabolic steroids.

This drug is very similar to nandrolone decanoate but does not contain Durabolin, but they have a shorter period of action.

The increase in muscle mass takes place in a smaller volume and at a slower pace than when using Decanoate, but the process is more qualitative and is mentioned for a longer time.

Phenandrol treatment requires caution in (or a history of) heart disease and circulatory disorders, liver and kidney dysfunction, epilepsy, migraine, and glaucoma.

During treatment with Fenandrol, it is recommended to check the intraocular pressure (eg eye pressure) regularly to establish a chance of sodium and water retention.

Hepatic impairment may occur, therefore liver function testing should be performed after 4 weeks of treatment.

Rectal examination of the prostate during treatment is recommended before starting treatment.

In patients with malignant tumors, the duration of treatment will be determined individually and according to liver parameters.

Like all medicines, this preparation can cause side effects.

Injection of nandrolone at therapeutic doses is unlikely to cause adverse reactions.

The following side effects have been observed during treatment: irreversible thickening of the voice, acne, hirsutism, clitoral hypertrophy, male pattern baldness, gynecomastia and inhibition of spermatogenesis, frequent erections and enlargement of the penis, change in libido, severe appetite.

The dose with this drug is more than nandrolone decanoate.

The dose varies between 50-200 mg per injection, which is about 150-600 mg/week in total.

Injections should be given every 2-3 days.